166 related articles for article (PubMed ID: 3071743)
21. Role of gastrin-releasing peptide in pepsinogen secretion from the isolated perfused rat stomach.
Skak-Nielsen T; Holst JJ; Christensen JD; Fjalland B
Regul Pept; 1988 Oct; 23(1):95-104. PubMed ID: 3148968
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ.
Johnson DG; Ensinck JW; Koerker D; Palmer J; Goodner CJ
Endocrinology; 1975 Feb; 96(2):370-4. PubMed ID: 1089535
[TBL] [Abstract][Full Text] [Related]
23. Effects of porcine intestinal heptacosapeptide and vasoactive intestinal polypeptide on insulin and glucagon secretion in rats.
Szecówka J; Lins PE; Tatemoto K; Efendić S
Endocrinology; 1983 Apr; 112(4):1469-73. PubMed ID: 6339205
[TBL] [Abstract][Full Text] [Related]
24. [Ala6]gastrin-releasing peptide-10: an analogue with dissociated biological activities.
Mukai H; Kawai K; Suzuki S; Ohmori H; Yamashita K; Munekata E
Am J Physiol; 1989 Aug; 257(2 Pt 1):E235-40. PubMed ID: 2669516
[TBL] [Abstract][Full Text] [Related]
25. Role of endogenous nitric oxide in the control of exocrine and endocrine pancreatic secretion.
Bilski J; Konturek SJ; Bielański W
J Physiol Pharmacol; 1995 Dec; 46(4):447-62. PubMed ID: 8770789
[TBL] [Abstract][Full Text] [Related]
26. Gastrin releasing peptide augments glucose mediated 45Ca2+ uptake, electrical activity, and insulin secretion of mouse pancreatic islets.
Wahl MA; Plehn RJ; Landsbeck EA; Verspohl EJ; Ammon HP
Endocrinology; 1991 Jun; 128(6):3247-52. PubMed ID: 2036987
[TBL] [Abstract][Full Text] [Related]
27. Studies on the mechanisms by which gastrin releasing peptide potentiates glucose-induced insulin secretion from mouse islets.
Gregersen S; Ahrén B
Pancreas; 1996 Jan; 12(1):48-57. PubMed ID: 8927619
[TBL] [Abstract][Full Text] [Related]
28. Effects of galanin and calcitonin gene-related peptide on insulin and glucagon secretion in man.
Ahrén B
Acta Endocrinol (Copenh); 1990 Dec; 123(6):591-7. PubMed ID: 1704674
[TBL] [Abstract][Full Text] [Related]
29. Effects of PHI on hormonal secretion from perfused rat pancreas.
Szecówka J; Tendler D; Efendić S
Am J Physiol; 1983 Oct; 245(4):E313-7. PubMed ID: 6137956
[TBL] [Abstract][Full Text] [Related]
30. Effects of calcitonin gene-related peptide (CGRP) on islet hormone secretion in the pig.
Ahrén B; Mårtensson H; Nobin A
Diabetologia; 1987 May; 30(5):354-9. PubMed ID: 2886386
[TBL] [Abstract][Full Text] [Related]
31. Gastrin-releasing peptide: pharmacokinetics and effects on gastro-entero-pancreatic hormones and gastric secretion in normal men.
Knigge U; Holst JJ; Knuhtsen S; Petersen B; Krarup T; Holst-Pedersen J; Christiansen PM
J Clin Endocrinol Metab; 1984 Aug; 59(2):310-5. PubMed ID: 6736205
[TBL] [Abstract][Full Text] [Related]
32. Endocrine responses to exogenous bombesin and gastrin releasing peptide in conscious calves.
Bloom SR; Edwards AV; Ghatei MA
J Physiol; 1983 Nov; 344():37-48. PubMed ID: 6361234
[TBL] [Abstract][Full Text] [Related]
33. Galanin: effects on basal and stimulated insulin and glucagon secretion in the mouse.
Lindskog S; Ahrén B
Acta Physiol Scand; 1987 Mar; 129(3):305-9. PubMed ID: 2437768
[TBL] [Abstract][Full Text] [Related]
34. Modulation of arginine-induced insulin and glucagon secretion by the hepatic vagus nerve in the rat: effects of celiac vagotomy and administration of atropine.
Tanaka K; Inoue S; Nagase H; Takamura Y
Endocrinology; 1990 Oct; 127(4):2017-23. PubMed ID: 2205480
[TBL] [Abstract][Full Text] [Related]
35. Evidence for a direct inhibitory effect of PYY on insulin secretion in rats.
Bertrand G; Gross R; Roye M; Ahrén B; Ribes G
Pancreas; 1992; 7(5):595-600. PubMed ID: 1513807
[TBL] [Abstract][Full Text] [Related]
36. Diminished insulinotropic effects of gastrin-releasing peptide in pregnant sheep are reproduced by progesterone treatment of nonpregnant animals.
Houghton PE; McDonald TJ; Challis JR
Endocrinology; 1992 Nov; 131(5):2337-43. PubMed ID: 1425433
[TBL] [Abstract][Full Text] [Related]
37. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
Parkes DG; Pittner R; Jodka C; Smith P; Young A
Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
[TBL] [Abstract][Full Text] [Related]
38. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
[TBL] [Abstract][Full Text] [Related]
39. Synthetic gastric inhibitory polypeptide. Stimulatory effect on insulin and glucagon secretion in the rat.
Taminato T; Seino Y; Goto Y; Inoue Y; Kadowaki S
Diabetes; 1977 May; 26(5):480-4. PubMed ID: 323091
[TBL] [Abstract][Full Text] [Related]
40. Nervous control of pancreatic endocrine secretion in pigs. I. Insulin and glucagon responses to electrical stimulation of the vagus nerves.
Holst JJ; Grønholt R; Schaffalitzky de Muckadell OB; Fahrenkrug J
Acta Physiol Scand; 1981 Jan; 111(1):1-7. PubMed ID: 7013421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
